Kenan Begovic
About Kenan Begovic
Company
Kenan Begovic currently holds the position of Microbiology Assistant Scientist at Bristol Myers Squibb in Syracuse, New York, United States. His tenure at the company spans multiple roles; he initially worked as a Microbiologist for 9 months from 2018 to 2019 before transitioning to his current role. Bristol Myers Squibb is a renowned pharmaceutical company where Kenan contributes to the development of microbiological assays.
Title
Kenan Begovic is a Microbiology Assistant Scientist. In this role, he is involved in the development and validation of microbiological assays. With expertise in microbiology and immunology, he applies his academic knowledge to practical research and development tasks in a leading pharmaceutical company.
Education and Expertise
Kenan Begovic completed his Master of Science in Microbiology and Immunology at the State University of New York at Buffalo - School of Medicine & Biomedical Sciences from 2019 to 2020. He previously earned a Bachelor of Science in Biological Sciences with a pre-health concentration from the University at Buffalo from 2014 to 2018. His educational background solidifies his expertise in microbiology, further evidenced by his participation in a research project focused on antimicrobial resistance and the publication of a research paper on probiotics and gut microbiota.
Background
Kenan Begovic has a diverse work history, having held roles such as Resident Assistant and Vice President of Communications at the University at Buffalo. He also gained retail experience as a Sales Associate at Burlington Stores, Inc. and Kmart Corporation. His background includes mentoring undergraduate students in microbiology lab techniques and volunteering at a local community health clinic during his undergraduate studies. These experiences, alongside his academic achievements, contribute to his well-rounded skill set.
Achievements
Kenan Begovic's achievements include presenting a poster on microbial pathogenesis at a national microbiology conference and completing a certification in Good Laboratory Practice (GLP) standards. He has also published a research paper on the effects of probiotics on gut microbiota in a peer-reviewed journal, solidifying his contributions to the field of microbiology. His efforts in developing microbiological assays at Bristol Myers Squibb and his active participation in research projects during his Master's program highlight his dedication and expertise.